Article

Association between promoter polymorphisms of vascular endothelial growth factor gene and sporadic Alzheimer's disease among Northern Chinese Han.

Department of Neurology, Xuan Wu Hospital of the Capital Medical University, Beijing 100053, China.
Neuroscience Letters (Impact Factor: 2.06). 08/2009; 457(3):133-6. DOI: 10.1016/j.neulet.2009.03.078
Source: PubMed

ABSTRACT Increasing evidences suggest that polymorphisms within the promoter region of the vascular endothelial growth factor (VEGF) gene may elevate the risk for Alzheimer's disease (AD). In Northern Chinese Han, we found three polymorphisms in the VEGF promoter: -2578C/A (rs699947), -2549I/D (rs35569394) and -1154G/A (rs1570360). A strong linkage disequilibrium was detected between -2578C/A and -2549I/D. After adjusting the data by gender, age and the APOEepsilon4 status using logistic regression, the -1154G/G genotype was found to increase the risk for sporadic AD (SAD) by 1.4-folds. In the subgroup of APOEepsilon4 non-carriers, the -1154G allele and -2549D/-1154G haplotype were observed to be significantly higher in the 279 SAD patients than in the 317 healthy individuals. The present study provides the evidence that the -1154G allele and the -2549D/-1154G haplotype may be associated with the development of SAD in the individuals without APOEepsilon4 allele.

0 Followers
 · 
145 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The purpose of this study was to evaluate the association of seven VEGF promoter polymorphisms with breast cancer risk in Punjabi population from North West India. We screened DNA samples of 102 sporadic breast cancer patients and 102 unrelated healthy, gender, and age-matched individuals for seven VEGF promoter polymorphisms [-417C/T (rs833062), -172C/A (rs59260042), -165C/T (rs79469752), -160C/T, -152G/A (rs13207351), -141A/C (rs28357093) and -116G/A (rs1570360)] by direct sequencing. The frequency of GG, GA, and AA genotype of -152G/A polymorphism was 26.47 vs 38.34 %, 46.08 vs 51.96 %, and 27.45 vs 9.80 %, in patients and controls, respectively. VEGF -152 AA genotype was significantly associated with increased risk for breast cancer (OR = 4.04, 95 %CI, 1.69-9.68, p = 0.001; recessive model OR = 3.48, 95 %CI, 1.59-7.63, p = 0.001). For VEGF -116G/A polymorphism, G and A allele frequencies were 65.2 vs 76.47 % and 34.8 vs 23.53 % in patients and controls, respectively. Individuals having -116AA genotype (OR = 3.40; 95 %CI, 1.24-9.37; p = 0.014) and A allele (OR = 1.73; 95 %CI, 1.12-2.67; p = 0.012) were associated with increased risk for breast cancer. VEGF -165C/T and -141A/C polymorphisms were associated with reduced risk for breast cancer. There was significantly decreased frequency of CT genotype (4.90 vs 18.63 %; p = 0.002) and T allele (2.45 vs 9.31 %; p = 0.003) of -165C/T polymorphism among breast cancer patients as compared to controls. VEGF -141A and C allele frequency were 96.57 vs 91.18 % and 3.43 vs 8.82 % in patients and controls, respectively. Significant reduced risk for breast cancer was observed with AC genotype (OR = 0.34, 95 %CI, 0.14-0.86; p = 0.019) and C allele (OR = 0.37; 95 %CI, 0.15-0.89; p = 0.023) of -141A/C polymorphism. We did not observe association of VEGF -417T/C, -172C/A, -160C/T polymorphisms with breast cancer risk in the studied subjects (p > 0.05). The VEGF -152G/A and -116G/A polymorphisms were found to be significantly associated with increased risk for breast cancer while -165C/T and -141A/C polymorphisms were found to be associated with decreased risk for breast cancer in Punjabi population from North West India.
    Tumor Biology 08/2014; 35(11). DOI:10.1007/s13277-014-2404-0 · 2.84 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Three regulatory SNPs (rSNPs) in the promoter region of the vascular endothelial growth factor-A (VEGFA) gene have been significantly associated with several human diseases or conditions. The rSNP alleles alter the DNA landscape for potential transcriptional factors to attach, resulting in changes in transcriptional factor binding sites (TFBS). These TFBS changes are examined with respect to the human diseases which have been found to be significantly associated with the rSNPs.
    The Journal of Physiological Sciences 10/2013; 64(1). DOI:10.1007/s12576-013-0293-4 · 1.25 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Allele and genotype frequency distributions of polymorphism rs2076059 (3832T>C) within the SELE gene, rs6131 (S290N), within the SELP gene, rs1131498 (F206L), within the SELL gene, rs5498 (K469E) within the ICAM1 gene, rs35569394 (−2549(18)I/D) within the VEGFA gene, and rs1024611 (−2518A>G) within the CCL2 gene were examined in a group of patients after myocardial infarction (MI)(280 individuals) and in a control group (312 individuals). An implementation of the Markov chain and Monte-Carlo method (APSampler) revealed the allele combinations associated with decreased and increased risk of MI. Among these, the most important allele combinations were SELE*C + SELP*S + CCL2*A (FDR = 0.0005; OR = 0.42), SELP*S + CCL2*A (FDR = 0.0009; OR = 0.36), SELL*F + VEGFA*I + CCL2*G/G (FDR = 0.0009; OR = 4.17), VEGFA*I + CCL2*G/G (FDR = 0.0009; OR = 3.76), SELE*C + CCL2*A (FDR = 0.0023; OR = 0.47), and SELL*F + CCL2*G/G (FDR = 0.003; OR = 3.15).
    Russian Journal of Genetics 02/2014; 50(2). DOI:10.1134/S1022795414020112 · 0.41 Impact Factor